Along with the approval, Sun Pharma is introducing an access program to assist eligible patients in starting and adhering to the treatment.

Combining electrocoagulation with pharmacotherapy significantly reduced keloid scar volume by inhibiting collagen deposition, angiogenesis, and cell proliferation.

In a milestone year for Dermatology Times, our Editorial Advisory Board reflects on how the publication has impacted their practice.

The study highlights the need for personalized treatments, suggesting that this combination therapy is most beneficial when tailored to individual risk profiles.

A systematic review of 31 studies found that patients with EBA responded well to rituximab with few adverse effects.

Compared to a stapling device, Xkin reduced scarring, pain, and infection risk more effectively in surgical and trauma wounds.

Data from numerous studies identified fluorouracil 5% as ranking the most effective across 3 outcomes.

Researchers behind the phase 3 studies gave pearls into the study methods, results, and what is up next.

Social media misinformation related to acne vulgaris may require clinician intervention when discussing treatment with patients.

Margins < 1 mm also do not increase the risk of cutaneous squamous cell carcinoma recurrence risk if the galea aponeurotica is not involved.

A recent study saw a “significant” decrease in allergen-specific IgE levels over a 1-year period of dupilumab therapy in children with atopic dermatitis.

Of those who have reported latex allergy, approximately 75% are health care workers. What should practice owners and managers need to consider legally?

Renata Block, MMS, PA-C, interviews dermatology clinicians and the Melanoma Research Foundation CEO at the Chicago SPF Fest.

A recent study examined skin manifestations and SS from a dermatological perspective.

Researchers noted that many dermatologists face mild, non-life-threatening complications during procedures, yet must be prepared for emergencies.

A recent review investigated all known information between skin conditions and sleep disorders, finding a bidirectional influence between them.

The submission to the FDA is supported by positive results from the ARRECTOR phase 3 trial.

Explore various elements that can go into a comprehensive insurance benefits package for dermatology practice employees.

In a milestone year for Dermatology Times, our Editorial Advisory Board reflects on key career mentors.

Spherix Global Insights recently delved into the efficacy, patient quality of life, and symptom management of adalimumab vs secukinumab.

Oral dimethyl fumarate improved all disease classification criteria for plaque psoriasis, showing significant betterment of severity and quality of life.

The guidelines for BCC and SCC treatment with IGSRT detail diagnosis, staging, contraindications, protocols, and emphasize the essential role of a multidisciplinary team.

Researchers examined the role of diabetes and glycemic profile in the risk of development of vitiligo in a Mendelian randomization study.

Robert Posnick, MD, hosted a Case-Based Roundtable discussion to review 2 challenging cases of atopic dermatitis involving hyperpigmentation and alopecia areata.

Keep up with the latest headlines in dermatology from the past week, including racial disparities in hidradenitis suppurativa, Stanford Medicine's new Skin of Color program, and more.